Luận văn thạc sĩ quản trị kinh doanh quốc tế MBA (128)

TOPIC: BUILDING BUSINESS STRATEGY DOMESCO MEDICAL IMPORT-EXPORT JOINTSTOCK COMPANY IN THE PERIOD 2010 - 2014 Group No.: Student’s Name: Le Quang Huy Nguyen Duy Ky Nguyen Thanh Nguyen Bui Ngoc Thiên Y Bui Tat Thanh THANKS Over time study learning Master of Business Administration International Program by Griggs University (United States), members of group was collected by many important knowledge , help work management in our company Special subjects "Strategic Management" is a general knowledge of all subjects before, helps businesses manage a panoramic view of their business, helping us options and planning strategies for business units With topics that the group seven made the following, taken from a practical business unit in Vietnam where a member of the working group We sincerely appreciate your guidance teachers in subject areas, as well as teachers of the program have suggestions for us to complete the subject We would like to thank leaders of Domesco Medical Export-Import Joint stock company created conditions, providing information and data for us perform written papers of us Collective group CERTIFICATION Representatives Domesco Medical Export-Import Joint stock company - Vinh Branch confirming that we provide data and information of the company within the research project for them: Le Quang Huy Nguyen Duy Ky Nguyen Thanh Nguyen Bui Ngoc Thien Bui Tat Thanh to proceed with writing their projects I confirm the data on the exact information with content that Domesco Medical Export-Import Joint stock company allowed in all public companies DOMESCO MEDICAL IMPORT EXPORT JOINT STOCK COMPANY VINH BRANCH DIRECTOR Pharmacist LE PHU SUNG TABLE OF CONTENTS Page no INTRODUCTION……………………………………………………………………………… 10 The urgency of the subject ………………………………………………………… 10 Research purposes………………………………………………………………… 11 Objects and scopes of the research:…………………………………………………11 Research methodology:…………………………………………………………… 12 Structure of subjects ……………………………………………………………….12 CHAPTER I: THEORETICAL BASIC……………………………………………………… 13 CONCEPTS, CONTENT OF STEP USED IN BUILDING BUSINESS STRATEGIES………………13 1.1.1 The concept of business strategy:………… ……………………………………….13 1.1.2 The steps to build strategy: ………………………………………………………14 1.1.2.1 The stage sets up strategy ………………………………………………………14 1.1.2.2 The stage of implementing strategy………………………………………………14 1.1.2.3 The stage of evaluating strategy……………………………………………….14 1.2 ANALYSIS OF BUSINESS ENVIRONMENT ACCORDING TO PEST: ……………… ……15 1.2.1 Institutional factors – the Law …………………………………………………….15 1.2.2 Economic factors………………………………………………………………….16 1.2.3 The socio-cultural factors:…………………………………………………………16 1.2.4 Technological factors …………………………………………………………….17 1.3 ENVIRONMENTAL ANALYSIS ACCORDING TO MICHEAL PORTER:………17 1.3.1 The competitive pressure of suppliers………………………………………………18 1.3.2 The competitive pressure from customers………………………………………….19 1.3.3 The competitive pressure from potential entrants:……………………… .… 19 1.3.4 The competitive pressure from substitute products:………………………………20 1.3.5 Internal competitive pressure in the industry……………………………………20 1.4 COMPANY ANALYSIS BASED ON SWOT…………………………………….…21 1.5 BCG GROWTH MATRIX MODEL……………….…………………………………22 CHAPTER II: REAL SITUATION OF ENTERPRISE ANALYSIS …… …………………24 2.1 OVERVIEW OF DOMESCO ………………………………………………………24 2.1.1 General Information, the process of formation and development of Company……24 2.1.1.1 General information about the company…………………………………………24 2.1.1.2 Development History…………………………………………….………………24 2.1.2 Functions and tasks of the company…………………………………….……….25 2.1.2.1 Main line of business…………………………………………………….…… 25 2.1.2.2 Other services:…………………………………………………………….…….25 2.1.3 The Company's main products include:…………………………………….……25 2.1.4 Organizational structure of management ……………………………….……26 2.1.5 Core Values……………………………………………………………………….27 2.1.5.1 Ambition: ……………………………………………………………… …… 27 2.1.5.2 Objectives………………………………………………………………….…….27 2.1.5.3 Vision……………………………………………………………………….…….27 2.1.5.4 Mission…………………………………………………………………….…….27 2.1.5.5 The cultural identity: Solidarity, sharing and developing the community……27 2.1.5.6 Business philosophy:……………………………………………………………27 2.1.5.7 Slogan: DOMESCO - for quality of life………………………………….……28 2.1.5.8 Logo: The logo of the two acronyms - Dong Thap…………………………….28 2.1.6 Location of Domesco in industry …………………………………………………28 2.1.6.1 About Revenue …………………………………………………………………29 2.1.6.2 Market share and distribution system………………………………………….28 2.2 OVERVIEW OF THE VIETNAM PHARMACEUTICAL INDUSTRY ………………………29 2.2.1 Industry is in growth phase……………………………………………………….29 2.2.1.1 Increased drug consumption:……………………………………………………29 2.2.1.2 Production growth:………………………………………………………………30 2.2.1.3 Increase the business standard:…………………………………………………31 2.2.2 Depending materials import………………………………………………………32 2.2.3 Main products are not high in value………………………………………………32 2.2.4 Distribution system characteristics……………………………………….………32 2.2.4.1 Treatment System………………………………………………………………33 2.2.4.2 Trading System:…………………………………………………………………33 2.3 ANALYSIS RESULTS OF BUSINESS OF DOMESCO MEDICAL IMPORT EXPORT JOINT STOCK…34 2.3.1 Fluctuation assets analysis of the company ……………………………………34 2.3.2 Fluctuating capital Analysis of the Company……………………………………37 2.3.3 Results of business operations Analysis of the Company…………………………38 2.3.4 Financial index Analysis……………………………………………………….…41 2.3.5 Analysis of the ability to create money of company… ………………………….…43 2.3.6 Evaluation of the financial policy of the Company…………………………… 43 2.3.7 Analysis of financial potential compared to competitors…………………….… 44 2.3.8 Analysis Dupont compared to competitors……………………………………….45 2.3.9 The changes to the financial situation in 2009………………………………… 46 2.4 ANALYSIS BUSINESS ENVIRONMENT BASED ON PEST………… …………….49 2.4.1 Business environment analysis …………………………………………………….49 2.4.2 Analysis of environmental politics and law policy ………………………….… 50 2.4.3 Analysis of cultural – social environment ………………………………………52 2.4.4 Analysis of technological environment………………………………………… 53 2.5 Environmental analysis based on Michael Porter’s five forces ……………………53 2.5.1 Pressure from potential entrants:…………………………………………………53 2.5.2 Competitive pressure of suppliers …………………………………………………53 2.5.3 Competitive pressure from customers …………………………………………54 2.5.4 Competitive pressure from substitute products …………………………………54 2.5.5 Competitive pressure from internal industry : ………………………………….55 2.6 ANALYSIS OF THE COMPANY’S PRODUCTS STRUCTURE ACCORDING TO BCG ………………….58 2.6.1 Antibiotic group……………………………………………………………………58 2.6.2 Cardiovascular – diabetes group………………………………………………….59 2.6.3 Group of medicinal products, food, and functional food …….…………………59 2.6.4 Common products Group ………………………………………………….…….60 2.6.5 ANALYSIS COMPANY BASED ON SWOT MATRIX…………………………………61 CHAPTER III: BUILDING STRATEGY AND PERFORMANCE SOLUTIONS ………………64 3.1 DETERMINING OBJECTIVES AND STRATEGIES………………………… ………64 3.2 BUILDING STRATEGY ……………………………………………………………….65 3.2.1 Growth strategy ……………………………………………………………………65 3.2.2 Competitive strategy…………………………………………………………… 66 3.2.3 Differentiation strategy ……………………………………………… ………… 67 3.3 Roadmap implementation……………………………………………….……… 70 3.3.1 Priod 2010 …………………………………… ………………………………70 3.3.2.Priod 2011-2012 : ………………………………………………70 3.3.3.Priod 2013-2014 : ………………………………………… …………….70 3.4 SOME SOLUTIONS FOR BUSINESS STRATEGY……………………………………71 3.4.1 Financial strategy………………………………………………………………….71 3.4.2 Human resource solution………………………………………… …………….71 3.4.3 Solutions in manufacturing and products …………………………………………72 3.4.4 Marketing solutions……………………………………………………………….72 3.4.5 Distribution system solution………………………………………… …………73 3.4.6 Solutions for quality management and science and technology ………………74 CONCLUSION………………………………………………………………………….75 References : ………………………………………………………………………………76 LIST OF ABBREVIATIONS DMC : Domesco JSC : Joint Stock company WTO : World Trade Organization SWOT: Strengths, Weaknesses , Opportunities , Threats BCG: Boston Consulting Group Matrix PEST: "Political, Economic, Social, and Technological GDP : Gross Domestic Product ICB: Industry Classification Benchmark NaNo : Nanotechnology 10 Genetics:Gene 11 GPP :Good Pharmacy Practices 12 EBIT : Earnings Before Interest & Tax 13 ROE : Return On Equity 14 OTC: Over-the-counter 15 GSP : Good Supply Practice for Pharmaceutical Products 16 GMP: Good Manufacturing Pratice 17 GLP: Good Laboratory Practice 18 EBT : Electronic Benefit Transfer 19 CPI: Consumer price index LIST OF TABLES Page no Chapter II: REAL SITUATION OF ENTERPRISE ANALYSIS …24 Table 2.1 Company's asset fluctuation in the year 2008 .35 Table 2.2 Fluctuating capital of the company in 2008 37 Table 2.3 Results of business operations Analysis of the Company 38 Table 2.4 Financial costs of the company in 2007, 2008 40 Table 2.5 Table 2.5 :Financial index Analysis……………………………… 41 Table 2.6 Table 2.6: Analysis of the ability to create money of company………… 43 Table 2.7 Evaluation of the financial policy of the Company .44 Table 2.8 Analysis of financial potential compared to competitors 44 Table 2.9 Analysis Dupont compared to competitors…………………………… 45 Table 2.10 Situation of assets and capital resource of the Company 46 Table 2.11 : Comparison results of business operations in 2008 and 3, 2009 48 Table 2.12 Group graded on production, sales and profit groups products ……… 61 Table 2.13 SWOT Matrix ………………………………………………………… 62 LIST OF FIGURES,GRAPHS Page no Chapter I: Basis of methodology 13 Figure 1.1 Factors affecting the business environment in Pest ……… 15 Figure 1.2 Model analysis of five competitive pressure M Porter 18 Figure 1.3 TOWS Matrix 21 Figure 1.4 BCG Matrix 23 Chapter II: BUSINESS ANALYSIS THE ISSUE ……………….24 Figure 2.1 Structure of the company's apparatus 26 Figure 2.2 The proportion of the company's revenue by business sector in 2008 29 Figure 2.3 Graph drug consumption in Vietnam from 2001 to 2008 30 Figure 2.4 Graph drug spending money / capita from 1993 to 2008 30 Figure 5 Drug consumption in Vietnam from 1993 to 2008 30 Figure 2.6 Comparing enterprises VN standard GMP,WHO 1996 to 2008… 31 Figure 2.7 Graph export pharmaceutical raw materials into Vietnam 32 Figure 2.8 Graph materials imported into Vietnam 32 Figure 2.9 Structure drug distribution in hospitals in 2008 … ……………… 33 Figure 2:10 Table number of establishments in the system of treatment 33 Figure 2:11 The structure of the drug distribution trade system in 2008 34 Figure 2:12 Table structure commercial distribution system 34 Figure 2:13 Comparison Chart 10 countries most exported to VN 56 Figure 2:14 chart sales, some companies in Vietnam 57 Figure 2:15 The proportion of drugs imported into Vietnam…………………… 57 INTRODUCTION The urgency of the subject In trend the international economy integration More and more deep and wide in recent years has created many chance to enterprise but also has many difficulties and challenges There are many successful enterprise, asserts its position in the market but also have enterprise have suffered defeat because of strict law of the market They must compete with each other not only in quality but also price and other factors According to stair needs of Maslow , the first and most basic needs are physical and physiological, in particular such as breathing, eating, relaxing, sex, etc Therefore, human health is a key factor that has never been forgotten Today, society are mobilizing and developing with time, parallel with the results and achievements of scientific and technological activities take place by strong, the disease and the health of human are thus also problems that humanity today very mindful to the occurrence of these phenomena, pathological abnormalities that sometimes progress of science cannot keep up Standing before this great and urgent need, the health sector in general and in particular the pharmaceutical industry is becoming more important for the whole society According to WTO commitments route starting on January 1, 2009 Vietnam opened the retail market At that product on the market diversified types, rich patterns and designs Thus to survive and develop lasting business should scrap the self in all aspects of production and business activities from the investment and use of capital to organizations producing consumer products Enterprise must take advantage of that capability, opportunity and choice for themselves a proper direction In order to get this point, one of the necessary measures that each enterprise must build yourself a business strategy accordingly Pharmaceutical industry of Vietnam in WTO era, and has experienced extremely difficult periods, but was regarded as the industry is more profitable 10 STRENGTHS - S WEAKNESSES - W - Have a solid financial foundation in over 20 years, and - Human resource positions in having the support of local which is convenient in having sales and marketing are still weak bank loans and not professional - Product diversity with more than 400 items, special - Welfare regimes and wages are treatment products for cardiovascular and diabetes are not having competitive advantage against foreign companies stimulating the work of dedicated personnel - Having three production factories are GMP-WHO - Came from state enterprises, the standard as recommended by the World Health way of managing human resource Organization - Having are also calculated the State's bold, distribution system in 64 provinces yet well adapted to the context of Representative offices and branches are GDP standard and the market good at practicing on medicine distribution - Volume of production does not - Export - import activities shown prestige brand and meet the needs of the market product quality (export to USA, France, Hong Kong, - Highly dependent on Africa, Laos, Cambodia, etc.) pharmaceutical raw materials - Having system of comprehensive quality management: imported from Europe, India and ISO, GMP-WHO, GLP, GSP and GDP, GPP With wireless China technology and production is relatively modern - The transfer of goods from Simultaneously with the center for scientific research and warehouse to warehouse branches applications in companies - There is scientific collaboration between the Institute School - Company in scientific research and application of new technologies in production 62 in the region is still limited in time OPPORTUNITIES - O STRATEGIES - SO STRATEGIES- WO - Take advantage of preferential policies on Invest in modern machinery, advanced production Building transportation systems preferential loans and financial aid policies from technology of large pharmaceutical companies in the world quickly and promptly the State during the period the world economy to meet the production’s demand when the market share Research process to has not recovered increase and export growth manufacture pharmaceutical raw - Policies to encourage use of domestic products Promote research with the Institute - School to produce materials, active in the raw in general and the regulations in the use of 70% new products with high quality materials of production of drugs in the drug price health insurance - Opportunity to cover the larger markets due to product diversification - Quick access to modern science (due to the relation with the Institute – School, so the scientific research and development of new products, high technology is more convenient) THREATS- T STRATEGIES - ST STRATEGIES - WT - Many applications and new research in Coordinate with research institutes and update Cut off the production lines that medicine in the world requires industry in the information providing the oriented basis for the research have low output and cannot meet country must have new products to meet the of new products the business needs requirements of treatment To focus on marketing, increasing spending on Joint venture with foreign - Many good imported medicines are getting the marketing activities companies in the distribution market share stage - The foreign companies come to Vietnam will be allowed to directly distribute since 2010 63 CHAPTER III: BUILDING STRATEGY AND PERFORMANCE SOLUTIONS 3.1 DETERMINING OBJECTIVES AND STRATEGIES Developing sustainably in order to become a Group of Medicine - Functional Foods, having enough power to get a large market share in the country, raising prestige in the international markets to expand exports Investment for expansion and intensive research in development to create new products, new dosage forms with new technologies and equipment advanced enough to overcome the "technical barriers to international trade" ( International Technical Barriers to Trade - TBT) directed to export Development of investment aquaculture of pharmaceutical materials through forms of association and cooperation with multilateral objectives Organic certified as prerequisites for the implementation of new standards of Pharmacy Practice good breeding material (GAP Good Agriculture Practices) process to ISO 2000 The Company will cooperative venture, link with units inside the country and abroad in terms of production and import - export business Also, complete the distribution system across the country advanced to the company system leading pharmaceutical distribution in Vietnam It continues to invest in the development of special products of pharmaceutical chemistry, thereby replacing imported products It is parallel to proactively and develop bioindustry sector, specifically Nano and Gen in pharmacy Continue to maintain and develop quality management system comprehensively across the company Quality management must be connected to knowledge management to create a "Knowledge repository of the Company 64 Creating a staff with strong sciencial and techonoligical skill, in which 1/3 have a graduate degree as a foundation for long-term development of the company 3.2 BUILDING STRATEGY From the results obtained through analysis of state enterprises from the theory of strategic management in chapter two, we find that: Pharmaceutical industry is a huge power vacuum, competition is fierce; so, in order to survival and developet in this industry requiring enterprises to find a direction to go with the strengths of their differentiation In the period of 2010 - 2014, we offer a number of strategies for the company as follows: 3.2.1 Growth strategy Pharmaceutical market is always looking outward to stabilize fluctuations in demand by the relatively low level, but inside it's full of fluctuations, the product was born after treatment with better features, or better customer care will quickly replace the products previously existed even for decades Therefore in this market, which requires companies to constantly mobilize the scientific expertise and skills to access and develop relationships with customers Pharmaceutical market has two main target customers; they are treatement system customers and customers of private pharmacies With those two target customers, the way to approach and care is completely different If a customer focused mass treatment leading in quality or effectiveness of treatment; wherease, the private pharmacies have a factor that are most concerned by customers is about the price of the product With current revenues of Domesco of more than 60% focus on channels of distribution system, which partly confirms the quality of products and strategies for market penetration of distribution channel is relatively good This is a competitive advantage over rivals in the country at this time Therefore, keeping the market and developing market share for this market is to determine the focus and long-term business strategy of the company 65 For the channels of commerce markets mainly private pharmacies, building marketing programs and sales appeal of the matter is successful with the customer care regime will ensure reasonable maintenance and market development Thus, building a team of scientific research and application of continuous achievements and transformation of medicine, combined with building a marketing team of market research is very important issue The Company must understand the direction of the company's products to each customer different areas, to bring efficiency in both production and distribution 3.2.2 Competitive strategy From the analysis results of the SWOT matrix, we have launched the development strategy (S-O), competitive strategy (W-O), opposition strategy (S-T) and defensive strategies (W-T) However, in the current economic context, we think the company can not set focus to the four strategies on a perfect one, with limited resources; companies need immediate focus on “competitive strategy W – O” In this strategy, the company should implement and perfect the earliest delivery system in the country With 08 branches located in 64 provinces stretching is not sufficient to cover freight and timely - most quickly to customers, so companies should consider several issues such as: ♦ Divide the area branch by the number of administrative units and the area is relatively reasonable May establish additional 2-3 branches reaching GDP in northern areas (especially the Northwest) and the Central Highlands ♦ In addition to the two current inventories, it is necessary to build two warehouses reaching GSP in Centre and North to provide timely branches in the region 66 ♦ Implement construction Pharmacies reaching GPP standard in branches to introduce products that branches are provided, directed to the construction of each province has at least one pharmacy GPP standard of Domesco The market in country is dependent on raw materials mainly from foreign countries, carriers of the disease risks of price and quality as well as degrading a profit In particular, most products are used by pharmaceutical raw materials Therefore the company will take advantage of this opportunity to invest in research and production of pharmaceutical raw materials active in the production and become suppliers of raw materials for other companies in the country 3.2.3 Differentiation strategy To develop and compete better, the company should be concentrated on the BCG growth model as analyzed above Products the image of "star" heading in cardiovascular diabetes group found not only bring high profits for the company but also the big difference of a domestic company in the pharmaceutical market Vietnam, this is a very distinct advantage of Domesco than domestic competitors, competition with foreign rivals Thus, in order to continue competing with the market and captured the majority of companies should continue to focus on this group and develop more products that treat cardiovascular function diabetes with premium features over Vietnam, and necessarily name registration for special pharmaceutical products to create a definition for each product the company To get this point, it should coordinate the development strategy SO as SWOT analysis matrix It means that companies need to step up cooperation with research institute-school to study the new products, and investment lines of modern machinery and advanced manufacturing technology to meet production demands in quantity and quality Also, the research and creation of new products with biotechnology: Gen and Nano is an very important work This is the area where businesses about Vietnam's investment focus because it is quite new, so go ahead bring many challenges but opportunities to create competitive advantage in the large difference chemical products company Also, many will 67 take advantage of investment opportunities for foreign affiliate of Vietnam, as the basis and premise for the long-term development orientation of the pharmaceutical in Vietnam Find out this chance, Domesco has to quickly deploy this stage to create advantages In addition, the investment and development of more groups added in pharmaceutical, food, functional food also can not miss work in strategic product development company As the main source of medicinal raw material is in the ability of Domesco, so take advantage of raw materials to develop natural products for preventive Domesco will take advantage of the domestic market and exported to other countries Japan, Europe, etc This is a product line offers high profit business enterprise that a pharmacist cannot be ignored 3.3 Roadmap implementation 3.3.1 Period 2010 Complete transportation and logistics system in 2010 with the construction of a complete inventory of regional climate and achieve delivery vehicles from the warehouse to warehouse areas, warehouse to warehouse area branch, along with distribution network GDP and GPP standard drugs Review the list of goods existing company, select products with sales and high profits, in line with the business strategy of the company to continue production and distribution Focused products make a difference in the goods to compete with rivals 3.3.2 Period 2011 - 2012: Implement Plant breeding and extract medicinal herbs Research and development of medicinal products, foods, functional foods with the lowest cost but focus on the features using the product Human search for the new high-level expertise, continuing training and development to improve their science and technology, to meet long-term goals of the company 3.3.3 Period 2013 - 2014: 68 Grasp the development trend of the industry, the advancement of science and technology, human needs of investment research new products with biotechnology and the Nano Gen Continue to invest in technology development group of products Cardiology - diabetes 3.4 SOME SOLUTIONS FOR BUSINESS STRATEGY 3.4.1 Financial strategy Established an own company, specializing in breeding and medicinal extracts first to reduce production cost and supply for other companies to profit, and take advantage of preferential tax policies of the State water for pharmaceutical manufacturing enterprises newly established Besides mobilizing new capital, take advantage of interest in the policy period is for more state incentives Implementing Circular No 130/2008/TT-BTC on December 26, 2008 to remove and control expenses negatively (as the account is not tax deductible), with the financial results for the highest profit 3.4.2 Human resource solution Planning forces personnel are managers Continuing to associate with The University of Medicine & Pharmacy at Ho Chi Minh City to train pharmacists in school to university, to meet the requirements of the roadmap of implementing GDP and GPP in accordance with the Ministry of Health Construction mode salary - bonuses to officials and employees according to company capabilities and the level of contributions of personnel to promote and take advantage of labor productivity, to ensure fairness for public officials and employees of the company and retain capable personnel Associated with the university to find new sources of personnel, investment and development to high school and working long-term commitment In the same time, 69 cooperation with institutions - schools, call the Officer level of scientific research in certain areas or certain product 3.4.3 Solutions in manufacturing and products The company continues to produce and develop products treating heart - diabetes such as Dorover, Dopili, Dopivix, Dochicin, etc focus on product registration in the name of special medicines, facilitate the work involved contractors and supply these products to the system of treatment Also, continuous research and for the life of pharmaceutical products treat heart diabetes new features preferential treatment under Vietnamese products have, such as Dorocron, Domerco, Doroco,etc Organizing, planning and cultivating medicinal plants soon complete construction of plant cultivation and extract medicinal herbs in order to stabilize raw materials and lower the cost of production for the group of pharmaceutical products, food, food function, increase revenue and profitability and dominant market through the provision of raw materials is the material Development of medicinal products, foods, functional foods such as Dotoni, DOGARLIC, etc in the Vietnam market and promote exports to countries such as Japan, Europe, etc 3.4.4 Marketing solutions Continuing to maintain pricing at less than the foreign companies with similar product lines, especially the characteristics of products, distribution channels for treatment, but higher than other companies in Vietnam (if any) to create and maintain brand image position for the company Building sales strategy timely in each period of the market, along with attractive promotions for commercial distribution channels 70 Organizing a marketing professional staff , performing the work of "customer service" as the focus of the business unit Capture medical information, regularly organizes seminars, scientific conferences, in order to update knowledge and information products for the company's physician, to create trust to customers Build a platform for product group "Cardiovascular - Diabetes", attracting the attention of doctors through the treatment information is always updated and close to practical work by the doctor reputation in the specialized hospitals first 3.4.5 Distribution system solution Complete sales management software in the ERP system distribution company, to create conditions for the control of goods - on and timely transfer of goods to the region, in time meet the needs of market Also, this software can monitor the recovery of debts Building distribution network until the commune, district and provincial branches of the 64 provinces stretching through the work of the organization's sales network Search facilities and construction equipment suitable for vehicle storage area and delivered online Deployed to build the system standard GPP pharmacies with eight branches GDP is to reach a complete distribution network reaching five GPs (WHO-GMP, GLP, GSP, GDP and GPP) across the country Search business partner links in export import and distribution; make the most of the costs spent on the construction of distribution systems in material and human Through this point, it is also a solution to reduce competition and increase the prestige of the company in the industry 3.4.6 Solutions for quality management and science and technology 71 Governance produced by sigma and Scada Management system with integrated management, including ISO 9001, ISO 14000, OHSAS 18000 and the GPS system is always being updated, improved and evaluated regularly Cut off the production lines that have low output and replace by the modern lines with a capacity higher Complete research process Dosage Creme curcumin + nano nano gold, nano particles lycopene in nanotechnology Tissue culture plant provides: Technology, village Conducted cooperation, study and perform with the science of DNA - RNA artificial 72 CONCLUSION Business strategy is an indispensable and extremely important part for every business unit worldwide Therefore, appreciating the business situation with the existing internal resources, but also capture the development trend of the market, the society, making sure we can build the strategy that is more appropriate for our business Building strategy is a focus, success or failure depends firstly on the strategy that we have built, then to implement and evaluate them Therefore, in our opinion, building a strategy is a very difficult thing; it requires the efforts of a group, people with intellectual and enthusiastic for the business The subject that group have already shown is the result of hard efforts of the collective group, it is a part we digested from subjects, but also research, inquiring information about the Domesco Corporation Hopefully in the near future, Domesco Medical Import Export Joint Stock Company will have developed rapidly for their own and contribute to the development of the whole society in the health care community In terms of time limits, restrictions on the research conditions, we have tried hard but certainly there are certain shortcomings We sincerely thanks for comments of teachers! 73 References : -http://www.domesco.com - Education Management Marketing - Publishing Statistics Author: Phillip Kotler - Catholic readers, up, analyze financial statements businesses - Publishing statistics Editor: Dr Ngo The Chi & TS Universe Corporation - Lesson financial enterprise production - Publishing Statistics Editor: TS Truong Moc Lam - Basic Education program-Publishing Marketing Statistics - Report on financial targets of the plan, financial settlements and other materials related the company Domesco period 2006-2009 - Catalog of catalogs, price lists and introduce company - A number of newspapers, other resource etc -Strategy administration discipline learning material- (United States of America) Griggs university's program GeMBA " Administration Maketing "- Philip Kokler, publisher is actuarial Book -Corporation Domesco intestine manual 74 ... pharmaceutical industry, the economy such as Vietnam have used theory and research, our group in class GeMBA.V01, choose topic: "BUILDING BUSINESS STRATEGY DOMESCO MEDICAL IMPORT EXPORT JOINT STOCK COMPANY... particular, with the objective view of the outsider after completion of subject Strategic Management of GeMBA Program of Griggs University; and with the subjective view of insider, we propose the solutions